ahlam1399
05-22-2015, 04:56 PM
Amgen first to win EU backing for new kind of cholesterol drug
(Reuters) - Amgen Inc's*closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sa**fi*SA.http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/468d6410/sc/21/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=KkF2jcsZcwM:nll30NHqD30:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=KkF2jcsZcwM:nll30NHqD30:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=KkF2jcsZcwM:nll30NHqD30:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=KkF2jcsZcwM:nll30NHqD30:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=KkF2jcsZcwM:nll30NHqD30:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/KkF2jcsZcwM
(Reuters) - Amgen Inc's*closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sa**fi*SA.http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/468d6410/sc/21/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=KkF2jcsZcwM:nll30NHqD30:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=KkF2jcsZcwM:nll30NHqD30:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=KkF2jcsZcwM:nll30NHqD30:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=KkF2jcsZcwM:nll30NHqD30:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=KkF2jcsZcwM:nll30NHqD30:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/KkF2jcsZcwM